Validating a measure of myalgic encephalomyelitis/chronic fatigue syndrome symptomatology.
Validating a measure of myalgic encephalomyelitis/chronic fatigue syndrome symptomatology.
复制标题
DOI:
10.1080/21641846.2014.928014
复制
发表时间:
2014
期刊:
影响因子:
--
通讯作者:
Jason LA
中科院分区:
文献类型:
--
作者:
Brown AA;Jason LA
The present study sought to validate a comprehensive self-report measure of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) symptomatology to aid in clinical and research assessment. Exploratory factor analysis (EFA) was used to establish the underlying factor structure of the DePaul Symptom Questionnaire (DSQ) using a well-characterized sample of individuals (92.6% met the and/or the Clinical Canadian Criteria), and this structure was then tested on a less stringently recruited sample of individuals utilizing a confirmatory factor analysis (CFA). Convergent and discriminant validity of the DSQ were also examined utilizing alternative measures of symptomatology and functioning. A 3-factor solution was found using EFA (Neuroendocrine, Autonomic & Immune Dysfunction; Neurological/Cognitive Dysfunction; Post-Exertional Malaise) and the fit of this factor structure was adequate for the second sample. The DSQ is a valid measure of ME/CFS symptomatology. The emergent factors were consistent with previous literature on symptom clusters, and convergent and discriminant validity were established.